138 related articles for article (PubMed ID: 17447051)
21. In vivo apparent pA2 analysis in rats treated with either clocinnamox or morphine.
Walker EA; Richardson TM; Young AM
Psychopharmacology (Berl); 1996 May; 125(2):113-9. PubMed ID: 8783384
[TBL] [Abstract][Full Text] [Related]
22. Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms.
Platt DM; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2001 Nov; 299(2):760-7. PubMed ID: 11602692
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice.
Divin MF; Holden Ko MC; Traynor JR
Eur J Pharmacol; 2008 Mar; 583(1):48-55. PubMed ID: 18275956
[TBL] [Abstract][Full Text] [Related]
24. Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.
Gatch MB; Negus SS; Mello NK; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Sep; 278(3):1282-9. PubMed ID: 8819513
[TBL] [Abstract][Full Text] [Related]
25. Antinociceptive and response rate-altering effects of kappa opioid agonists, spiradoline, enadoline and U69,593, alone and in combination with opioid antagonists in squirrel monkeys.
Pitts RC; Dykstra LA
J Pharmacol Exp Ther; 1994 Dec; 271(3):1501-8. PubMed ID: 7996463
[TBL] [Abstract][Full Text] [Related]
26. Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
France CP; Gerak LR
J Pharmacol Exp Ther; 1994 Sep; 270(3):992-9. PubMed ID: 7932212
[TBL] [Abstract][Full Text] [Related]
27. Cocaine-like discriminative stimulus effects of heroin in squirrel monkeys: role of active metabolites and opioid receptor mechanisms.
Rowlett JK; Spealman RD; Platt DM
Psychopharmacology (Berl); 2000 Jun; 150(2):191-9. PubMed ID: 10907672
[TBL] [Abstract][Full Text] [Related]
28. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
Dykstra LA; Gmerek DE; Winger G; Woods JH
J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
[TBL] [Abstract][Full Text] [Related]
29. Chronic l-alpha acetylmethadol in rhesus monkeys: discriminative stimulus and other behavioral measures of dependence and withdrawal.
Brandt MR; France CP
J Pharmacol Exp Ther; 1998 Dec; 287(3):1029-37. PubMed ID: 9864289
[TBL] [Abstract][Full Text] [Related]
30. Thienorphine: receptor binding and behavioral effects in rhesus monkeys.
Li JX; Becker GL; Traynor JR; Gong ZH; France CP
J Pharmacol Exp Ther; 2007 Apr; 321(1):227-36. PubMed ID: 17220427
[TBL] [Abstract][Full Text] [Related]
31. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
Barrett AC; Smith ES; Picker MJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):1061-70. PubMed ID: 12649297
[TBL] [Abstract][Full Text] [Related]
32. Maintenance on naltrexone+amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys.
Moerke MJ; Banks ML; Cheng K; Rice KC; Negus SS
Drug Alcohol Depend; 2017 Dec; 181():85-93. PubMed ID: 29040826
[TBL] [Abstract][Full Text] [Related]
33. Some effects of dopamine transporter and receptor ligands on discriminative stimulus, physiologic, and directly observable indices of opioid withdrawal in rhesus monkeys.
McMahon LR; Li JX; Carroll FI; France CP
Psychopharmacology (Berl); 2009 Apr; 203(2):411-20. PubMed ID: 18636243
[TBL] [Abstract][Full Text] [Related]
34. The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity.
Lee SC; Yoburn BC
Pharmacol Biochem Behav; 2000 Jun; 66(2):347-51. PubMed ID: 10880689
[TBL] [Abstract][Full Text] [Related]
35. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
Comer SD; Burke TF; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
[TBL] [Abstract][Full Text] [Related]
36. Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys.
Maguire DR; Gerak LR; Woods JH; Husbands SM; Disney A; France CP
J Pharmacol Exp Ther; 2019 Jan; 368(1):88-99. PubMed ID: 30401680
[TBL] [Abstract][Full Text] [Related]
37. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
38. In vivo characterization of the opioid antagonist nalmefene in mice.
Osborn MD; Lowery JJ; Skorput AG; Giuvelis D; Bilsky EJ
Life Sci; 2010 Apr; 86(15-16):624-30. PubMed ID: 20159022
[TBL] [Abstract][Full Text] [Related]
39. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
Zhang L; Walker EA; Sutherland J; Young AM
Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
[TBL] [Abstract][Full Text] [Related]
40. Discriminative stimulus effects of naltrexone after a single dose of morphine in the rat.
Easterling KW; Holtzman SG
J Pharmacol Exp Ther; 1999 Mar; 288(3):1269-77. PubMed ID: 10027868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
